Search Results

Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis.

• Authors : Jayne, David; Rovin, Brad; Mysler, Eduardo F.

Subjects: THERAPEUTIC use of monoclonal antibodies; GLUCOCORTICOIDS; RESEARCH

• Source: Annals of the Rheumatic Diseases; Apr2022, Vol. 81 Issue 4, p496-506, 66p

Record details

New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?

• Authors : Basu, Biswanath; Angeletti, Andrea; Islam, Bilkish

Subjects: MONOCLONAL antibodies; NEPHROTIC syndrome; FOCAL segmental glomerulosclerosis

• Source: Frontiers in Immunology; 2/11/2022, Vol. 13, p1-9, 9p

Record details

Efficacy and safety of an anti‐CD20 monoclonal antibody, rituximab, for lupus nephritis: A meta‐analysis.

• Authors : Teng, Siyuan; Tian, Yu; Luo, Nan

Subjects: LUPUS nephritis; MONOCLONAL antibodies; RITUXIMAB

• Source: International Journal of Rheumatic Diseases; Feb2022, Vol. 25 Issue 2, p101-109, 9p

Record details

Anifrolumab: First Approval.

• Authors : Deeks, Emma D.

Subjects: THERAPEUTIC use of monoclonal antibodies; DRUG approval; INTRAVENOUS therapy

• Source: Drugs; Oct2021, Vol. 81 Issue 15, p1795-1802, 8p

Record details

The Type II Anti‐CD20 Antibody Obinutuzumab (GA101) Is More Effective Than Rituximab at Depleting B Cells and Treating Disease in a Murine Lupus Model.

• Authors : Marinov, Anthony D.; Wang, Haowei; Bastacky, Sheldon I.

Subjects: THERAPEUTIC use of monoclonal antibodies; DRUG efficacy; RITUXIMAB

• Source: Arthritis & Rheumatology; May2021, Vol. 73 Issue 5, p826-836, 11p

Record details

From sequential to combination and personalised therapy in lupus nephritis: moving towards a paradigm shift?

• Authors : Parodis, Ioannis; Houssiau, Frederic A.

Subjects: THERAPEUTIC use of monoclonal antibodies; RESEARCH; LUPUS nephritis

• Source: Annals of the Rheumatic Diseases; Jan2022, Vol. 81 Issue 1, p15-19, 5p

Record details

Patent Application Titled "Compositions And Methods Of Treating Lupus Nephritis" Published Online (USPTO 20240033351).

Subjects: PATENT applications; INTERNET publishing; LUPUS nephritis

• Source: Women's Health Weekly; 2/23/2024, p1937-1937, 1p

Record details

贝利尤单抗用于儿童系统性红斑狼疮的研究进展.

• Authors : 邓伟萍; 综述胡长平; 罗平

Subjects: SYSTEMIC lupus erythematosus; CHILD patients; BELIMUMABCHINA

• Source: Chinese Journal of Contemporary Pediatrics; Oct2021, Vol. 23 Issue 10, p1069-1074, 6p

Record details

Study Results from Osaka Medical and Pharmaceutical University in the Area of Lupus Published (A successful plasma exchange in bridging to rituximab for severe neuropsychiatric lupus and lupus nephritis with viral infections and aspiration...).

Subjects: VIRUS diseases; LUPUS nephritis; RITUXIMAB

• Source: Immunotherapy Weekly; 1/12/2024, p434-434, 1p

Record details

Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders.

• Authors : Araten, David J.; Belmont, H. Michael; Schaefer-Cutillo, Julia

Subjects: COVID-19; MONOCLONAL antibodies; PATHOLOGY

• Source: American Journal of Case Reports; 9/12/2020, Vol. 21, p1-4, 4p

Record details